Precise Health is developing a Personalized Phage platform that utilizes bacteriophage technology combined with data science and machine learning to target and eliminate specific bacterial infections. This approach addresses the critical issue of antimicrobial resistance by providing precise alternatives to broad-spectrum antibiotics, reducing the risk of treatment failures and improving patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Antimicrobial resistance is a growing threat, rendering many traditional antibiotics ineffective against bacterial infections. Broad-spectrum antibiotics can disrupt the microbiome and lead to treatment failures, highlighting the need for more targeted therapies.
Solution
Precise Health is developing a platform that leverages bacteriophage technology, data science, and machine learning to create personalized treatments for bacterial infections. This approach offers a precise alternative to broad-spectrum antibiotics, minimizing disruption to the microbiome and reducing the risk of resistance. The platform identifies and engineers bacteriophages—viruses that specifically target bacteria—to eliminate harmful pathogens while preserving beneficial bacteria. By combining phage therapy with advanced analytics, Precise Health aims to improve patient outcomes and combat the rise of antimicrobial resistance.
Target Audience
The primary target audience includes hospitals, clinics, and research institutions seeking innovative solutions to combat antibiotic-resistant infections.
Features
- Phage discovery and engineering platform for identifying and optimizing bacteriophages against specific bacterial strains
- Machine learning algorithms to predict phage efficacy and personalize treatment regimens
- High-throughput screening to rapidly identify and characterize phage-bacteria interactions
- Proprietary phage delivery system to enhance phage stability and target specific infection sites